A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma. [electronic resource]
Producer: 20161213Description: 372-6 p. digitalISSN:- 1476-5365
- Adult
- Aged
- Autografts
- Cyclophosphamide -- administration & dosage
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hematopoietic Stem Cell Mobilization
- Hematopoietic Stem Cell Transplantation
- Humans
- Induction Chemotherapy -- adverse effects
- Lenalidomide
- Middle Aged
- Multiple Myeloma
- Thalidomide -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.